Gene regulation in temporally and spatially precise patterns is integral to normal developmental processes. Hormonal, tissue-specific and developmental regulation can be analyzed by molecular and genetic approaches in the C4/Slp gene family of the mouse major histocompatibility complex. C4, the fourth component of complement, is essential in the effector mechanism of humoral immunity. During evolution, the C4 gene has undergone duplication, allowing divergence with respect to function and regulation. The product of the duplicate gene, Slp (sex-limited protein), is structurally similar to C4, but does not participate in the complement pathway and is regulated by androgen. Extensive homology at the DNA level occurs in coding regions and upstream and downstream of these neighboring genes. Regulatory differences of both genes are found in congenic mouse strains and are due to allelic variation as well as nonlinked genes. Thus this serves as a model system in which to correlate differences in DNA sequence with differences in regulation; further comparison allows identification of specific factors in gene control.
The specific aims of this proposal are to define at the molecular level: I) cis-acting sequences involved in hormonal regulation; II) trans-acting factors that interact directly or indirectly with these sequences; III) interactions of cis and trans elements that specify developmental regulation. Cis-acting sequences will be defined by transfection of cloned genes and gene constructs. Hormonal regulation of Slp is due to an upstream enhancer element that derives from a proviral LTR; this element will be mutagenized to define internal domains and exact sequence requirements. Trans-acting factors will be identified by virtue of their sequence- specific binding. Biochemical characterization will aid isolation of genes encoding these proteins, whose function and regulation may then be more readily examined. Developmental regulation is particularly accessible to analysis in the C4/Slp system due to its genetics and because the major site of expression is liver, which is fully differentiated before, during and after transcriptional activation of Slp by androgen. Illumination of the molecular basis of Slp and C4 regulation will be relevant to general mechanisms of gene expression, hormonal control and evolution.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM031546-11
Application #
3279632
Study Section
Molecular Biology Study Section (MBY)
Project Start
1983-01-01
Project End
1994-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
11
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Ning, Y M; Robins, D M (1999) AML3/CBFalpha1 is required for androgen-specific activation of the enhancer of the mouse sex-limited protein (Slp) gene. J Biol Chem 274:30624-30
Scheller, A; Hughes, E; Golden, K L et al. (1998) Multiple receptor domains interact to permit, or restrict, androgen-specific gene activation. J Biol Chem 273:24216-22
Scarlett, C O; Scheller, A; Thompson, E et al. (1997) Involvement of an octamer-like sequence within a crucial region of the androgen-dependent Slp enhancer. DNA Cell Biol 16:45-57
Nelson, S A; Robins, D M (1997) Regulatory capacity of an androgen-specific enhancer of the mouse Slp gene in transgenic mice. Mol Cell Endocrinol 133:89-97
Nelson, S A; Robins, D M (1997) Two distinct mechanisms elicit androgen-dependent expression of the mouse sex-limited protein gene. Mol Endocrinol 11:460-9
Burgos-Trinidad, M; Youngblood, G L; Maroto, M R et al. (1997) Repression of cAMP-induced expression of the mouse P450 17 alpha-hydroxylase/C17-20 lyase gene (Cyp17) by androgens. Mol Endocrinol 11:87-96
Scarlett, C O; Robins, D M (1995) In vivo footprinting of an androgen-dependent enhancer reveals an accessory element integral to hormonal response. Mol Endocrinol 9:413-23
Adler, A J; Scheller, A; Robins, D M (1993) The stringency and magnitude of androgen-specific gene activation are combinatorial functions of receptor and nonreceptor binding site sequences. Mol Cell Biol 13:6326-35
Adler, A J; Danielsen, M; Robins, D M (1992) Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors. Proc Natl Acad Sci U S A 89:11660-3
Cox, B J; Robins, D M (1988) Tissue-specific variation in C4 and Slp gene regulation. Nucleic Acids Res 16:6857-70

Showing the most recent 10 out of 14 publications